Major Depressive Disorder (MDD) is a debilitating condition characterized by persistent feelings of sadness, hopelessness, and a lack of interest in daily activities. Understanding its underlying causes and effective treatments is crucial for patient well-being. The Journal of Clinical Psychiatry provides a comprehensive look into MDD, offering evidence-based therapeutic approaches and the latest research findings. Our expert editors ensure content is relevant and actionable, aiding psychiatrists in offering holistic care to those grappling with depression.
Depression and Major Depressive Disorder
Page 79
Recently published articles about Depression (MDD)
Letter to the Editor
Efficacy of Duloxetine and Agomelatine Does Not Exceed That of Other Antidepressants in Patients With Autistic Disorder: Preliminary Results in 3 Patients
February 24, 2011
The authors of this case report share results from a 10-week trial of duloxetine (40 mg daily) and agomelatine (25 mg daily) in 3 patients with autism.
Article
Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study
February 24, 2011
Read this article to examine results from a randomized, open-label, multicenter study that compared treatment outcomes with the serotonin-norepinephrine reuptake inhibitor venlafaxine extended release with selective serotonin reuptake inhibitors...
